Enhancer of the cytotoxic effect of immunotoxins (ITs) which results in increased apoptosis in different cancer cells

Mitochondria-activatable luciferin (MAL-Probe)

Novel Type-I Inhibitor of TIE-2

Potent I 2 -imidazoline receptor agonist

Metabolite of Resveratrol

Potent and selective NMDA agonist

Novel HuR binder, modulating HuR-RNA interactions

Novel KGA allosteric inhibitor

Natural resveratrol trimer, acting as a protein kinase C inhibitor

Natural specific inhibitor of γ-secretase, decreasing amyloid-beta levels without influencing cleavage of Notch, showing strong growth inhibitory effects on cancer cell lines and significant anti-complement activity, also acting as a PTP1B inhibitor

Metabolite of Resveratrol

Metabolite of Resveratrol

Novel Highly Selective β2-Adrenoceptor Agonist as an Oral Antiasthmatic Agent

Inhibitor of histone deacetylases

Novel TGR5 agonist, reducing glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

Central sugar signal in plants, regulating sucrose use and allocation, underpinning crop growth and development

Potent and long-acting derivative of the hormone Trenbolone

EC 3.1.1.7 (Acetylcholinesterase) inhibitor, acting as an insecticide, an acaricide, an agrochemical, and a nematicide

AKT Inhibitor, Enhancing Gemcitabine Activity in Pancreatic Cancer Cells

Potent NAE-hydrolyzing acid amidase (NAAA) inhibitor

Metabolite of Trifluoperazine; Antidepressant and antipsychotic

Novel Bromodomain Binding Mimic of Lysine Acetylation